Mobile Menu

Round-Up: COVID-19 January (Part Two)

Check out your fortnightly COVID-19 round-up – full of the latest news and research surrounding the novel coronavirus.


At the time of writing, there have been:

  • 352,239,850 cases
  • 5,615,085 deaths
  • 279,932,725 recoveries


  • UCB scientists have unveiled the world’s first molecular-level analysis of the Omicron spike protein. (Mannar et al, 2022)
  • A multi-ancestry genome-wide association study has found that the UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. (Shelton et al, 2022)
  • A new study has provided the first evidence that the presence of T cells from common colds at the time of SARS-CoV-2 exposure can influence infection. (Kundu et al, 2022)
  • A recent article explored what is currently known about the effects of SARS-CoV-2 on the brain and the possible ways to treat its symptoms. (Spudich and Nath, 2022)
  • Findings from a recent study have suggested that individuals who are depressed may be more susceptible to misinformation about COVID-19 vaccines. (Perlis et al, 2022)
  • A new study found that patients hospitalised for COVID-19 had higher levels over the short term of blood markers known to rise with neurological damage compared to Alzheimer’s patients. (Frontera et al, 2022)
  • An international study has identified a specific gene variant that protects against severe COVID-19 infection. (Huffman et al, 2022)
  • A machine-learning model has been found to be able to predict COVID-19 survival from a single blood sample from critically ill COVID-19 patients. (Demichev et al, 2022)
  • UCSF-led study has shown that cerebrospinal fluid may offer insights into post-COVID ‘brain fog’. (Leigh, 2022)
  • New research has found that antibodies in the blood of patients soon after COVID-19 onset may be able to help predict severity of infection. (Chakaraborty et al, 2022)
  • A new study has shown that a third dose of the Pfizer-BioNTech vaccine may offer protection against Omicron. (Muik et al, 2022)

Image credit: canva

More on these topics

Coronavirus / covid-19 / Genetic Variants / Round-up